BGLC
BioNexus Gene Lab Corp
Key Financials
Operating Income
$-1573702
↑ 39.3%
Revenue
$9.5M
↓ 2.7%
Net Income
$-1598342
↑ 39.2%
Gross Profit
$1.3M
↓ 3.0%
Total Assets
$10.4M
↓ 8.5%
Total Liabilities
$2.1M
↑ 21.2%
Shareholders' Equity
$8.3M
↓ 13.8%
EPS (Diluted)
$-0.09
↑ 45.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BGLC |
| Company Name | BioNexus Gene Lab Corp |
| CIK | 1737523 |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | WY |
| Phone | 1-307-241-6898 |